Crescent Pharma are committed to ensuring the manufacture of medicinal products to the highest quality, safety and efficacy by adhering to, and implementing quality systems in compliance with GMP and GDP.
Crescent Pharma is focused on increasing the intellectual property and product portfolio to a range of 600 generic, new combination and branded products by 2022.
Crescent Pharma Ltd, formed In 2003 is a fast growing, privately owned UK Company.
Crescent Pharma produce and market affordable generic medicines, as well as over-the-counter consumer healthcare products primarily to the UK market. Crescent Pharma are one of the leading enterprises in UK healthcare, supplying an extensive range of medicines to the UK’s National Health Service, working alongside the NHS and Department of Health to ensure patient supply and safety.
Crescent focused on a European and UK production strategy, currently manufactures approximately 200+ generic and branded products and is committed to the continual development and growth in the portfolio aiming to offer a wider and diverse range of medicines to the supply chain. Crescent is now exporting to over 40 territories globally although remaining primarily focused on the UK market with offices and a warehouse distribution network including depots in London, the South and North England. Despite substantial recent growth in all areas of the organisation, Crescent continues to demonstrate the same quality culture and Small Business values that it has been founded on to give all stakeholders the best possible experience when working with Crescent.
With a particular specialisation in generic medicine, Crescent are committed to enhancing the lives of patients across all therapeutic areas. Our medicines are supplied and used in hospitals, pharmacies, retail outlets and clinics. Generic medicines offer affordable alternatives to treat a vast range of medical conditions allowing healthcare systems to offer a wide range of products to put patients’ needs first whilst also managing their budget. Whilst quality is not compromised Generic medicines are manufactured to the same practices as their branded medicine equivalents but are normally able to be sold at lower price compared to branded medicine due to the lower development costs involved.
With over 350 UK Marketing Authorisations and a pipeline of a further 100 Marketing Authorisations in development Crescent are committed to providing a wide range medicines to the UK supply chain with over 150 million packs supplied into the UK market in 2019.
Regulation & Licensing
Warehouse & Distribution
Crescent Pharma & Crescent Pharma OTC
3 & 4 Quidhampton Business Units Polhampton Lane Overton Hampshire RG25 3ED
Telephone: +44 (0) 1256 772730
Fax: +44 (0) 1256 772740
Address: Key House, Sarum Hill, Basingstoke, Hampshire, RG21 8SR, UK